Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
1984-7-13
|
pubmed:abstractText |
Disease-free intervals of 2 to 3 years after treatment of histiocytic lymphoma are generally thought to represent cures; flat survival curves beyond 3 years in several studies support this notion. Four case reports of histiocytic lymphoma recurrences 25, 10, 9 and 6 years, respectively, after the initial diagnosis are presented. Histologic confirmation comparing primary and recurrent disease is presented. The potential biological significance of such patient reports is discussed.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0008-543X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
53
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2663-7
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6372982-Adult,
pubmed-meshheading:6372982-Aged,
pubmed-meshheading:6372982-Female,
pubmed-meshheading:6372982-Humans,
pubmed-meshheading:6372982-Lymphoma, Large B-Cell, Diffuse,
pubmed-meshheading:6372982-Male,
pubmed-meshheading:6372982-Middle Aged,
pubmed-meshheading:6372982-Neoplasm Recurrence, Local,
pubmed-meshheading:6372982-Time Factors
|
pubmed:year |
1984
|
pubmed:articleTitle |
Late recurrences of histiocytic lymphoma after treatment.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Case Reports,
Research Support, Non-U.S. Gov't
|